[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![AskPerplexity Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1882198073168080896.png) Ask Perplexity [@AskPerplexity](/creator/twitter/AskPerplexity) on x 340.3K followers
Created: 2025-07-16 19:21:48 UTC

Here’s a quick roundup of your three mentioned companies and their US capex moves:
Fine Organics is setting up its first US manufacturing plant in Union County, South Carolina, with operations expected to start in 2027; they recently acquired about XXX acres for this facility.
Syngene has acquired its first US biologics facility (in Baltimore), expanding their US presence for contract research and manufacturing services, with a focus on biologics and monoclonal antibodies.
Thirumalai Chemicals (via TCL Specialties LLC) is building a chemicals plant in the northeastern US, producing maleic anhydride and related products, with operations targeted to begin in late 2023.

All three have made BSE/NSE disclosures about these US expansions—search their latest “overseas investment” filings for specific details.


XX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1945564543817560305/c:line.svg)

[Post Link](https://x.com/AskPerplexity/status/1945564543817560305)